每年專案
個人檔案
學歷
- 國立臺灣大學醫學系學士
研究專長
- 婦產科學
- 婦科學
- 婦癌學
- 婦科腫瘤
指紋
查看啟用 Cheng-Yang Chou 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 8 類似的個人檔案
網路
國家層面的近期外部共同作業。通過按一下圓點深入探索詳細資料。
專案
研究成果
-
Chemoresistant ovarian cancer enhances its migration abilities by increasing store-operated Ca2+ entry-mediated turnover of focal adhesions
Huang, H. K., Lin, Y. H., Chang, H. A., Lai, Y. S., Chen, Y. C., Huang, S. C., Chou, C. Y. & Chiu, W. T., 2020 二月 21, 於: Journal of biomedical science. 27, 1, 36.研究成果: Article › 同行評審
開啟存取1 引文 斯高帕斯(Scopus) -
Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment
Wu, Y. H., Huang, Y. F., Chen, C. C., Huang, C. Y. & Chou, C. Y., 2020 三月 3, 於: Frontiers in Pharmacology. 11, 206.研究成果: Article › 同行評審
開啟存取3 引文 斯高帕斯(Scopus) -
Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year Experience
Wu, P. Y., Cheng, Y. M., Shen, M. R., Chen, Y. C., Huang, Y. F. & Chou, C. Y., 2020 七月 14, 於: Frontiers in Oncology. 10, 1095.研究成果: Article › 同行評審
開啟存取 -
A dose escalation study of trientine plus carboplatin and pegylated liposomal doxorubicin in women with a first relapse of epithelial Ovarian, Tubal, and peritoneal cancer within 12 months after platinum-based Chemotherapy
Huang, Y. F., Kuo, M. T., Liu, Y. S., Cheng, Y. M., Wu, P. Y. & Chou, C. Y., 2019, 於: Frontiers in Oncology. 9, MAY, 437.研究成果: Article › 同行評審
開啟存取5 引文 斯高帕斯(Scopus) -
Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression
Wu, Y. H., Huang, Y. F., Chen, C. C. & Chou, C. Y., 2019 四月 1, 於: Cell Death and Disease. 10, 4, 322.研究成果: Article › 同行評審
開啟存取11 引文 斯高帕斯(Scopus)